Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 9—September 2004

Research

SARS Antibody Test for Serosurveillance

Po-Ren Hsueh*1, Chuan-Liang Kao*1, Cun-Nan Lee*, Li-Kuan Chen†, Mei-Shian Ho‡, Charles Sia§¶, Xin De Fang§, Shugene Lynn¶, Tseng Yuan Chang§, Shi Kau Liu§, Alan M. Walfield§, and Chang Yi Wang§¶Comments to Author 
Author affiliations: *National Taiwan University College of Medicine, Taipei, Taiwan; †Tsu Chi University, Hualien, Taiwan; ‡Academia Sinica, Taipei, Taiwan; §United Biomedical, Inc., Hauppauge, New York, USA; ¶United Biomedical, Inc. Asia, Hsin Chu, Taiwan; 1Drs. Hsueh and Kao contributed equally to this article.

Main Article

Figure 1

Signal/cutoff (S/C) distribution of Center for Disease Control (Taiwan) SARS (severe acute respiratory syndrome) serum panel and blood donor serum panel. The mean signal/cutoff (S/C) ratio for the SARS samples was 8.08. The mean S/C for the 1,390 normal human plasma was 0.28.

Figure 1. Signal/cutoff (S/C) distribution of Center for Disease Control (Taiwan) SARS (severe acute respiratory syndrome) serum panel and blood donor serum panel. The mean signal/cutoff (S/C) ratio for the SARS samples was 8.08. The mean S/C for the 1,390 normal human plasma was 0.28.

Main Article

TOP